Ipsen/Exelixis’ drug approved in EU for kidney cancer
Cabometyx secures new indication in renal cell carcinoma.
X
Ipsen/Exelixis’ drug approved in EU for kidney cancer
https://pharmaphorum.com/news/ipsenexelixis-drug-approved-eu-kidney-cancer/
Cabometyx secures new indication in renal cell carcinoma.
